Marshall Ken W. 4
4 · Aquestive Therapeutics, Inc. · Filed Sep 20, 2019
Insider Transaction Report
Form 4
Marshall Ken W.
Commercial Leader
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-09-18+66,000→ 66,000 totalExercise: $3.49Exp: 2029-09-18→ Common Stock (66,000 underlying)
Holdings
- 1,445(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.
- [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.